All sponsors

NS Pharma, Inc.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS7
PHASE 3 / 2-31
RECRUITING2
READOUTS ≤12 MONTHS2
Open NS Pharma, Inc. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Viltolarsen
NCT04768062
P3Active, not recruitingDuchenne Muscular Dystrophy742025-10
NS-229
NCT06046222
P2Active, not recruitingEosinophilic Granulomatosis With Polyangiitis; Churg-Strauss Syndrome452026-12 (+20 mo)
NS-089/NCNP-02
NCT05996003
P2Active, not recruitingDuchenne Muscular Dystrophy; Exon 44202027-02-26 (+21 mo)
NS-050/NCNP-03
NCT06053814
P1/2Active, not recruitingDuchenne Muscular Dystrophy202028-03 (+21 mo)
NS-863 Low Dose
NCT07441200
P2RecruitingPulmonary Arterial Hypertension1352028-08-01
NS-863 Low Dose
NCT07441278
P2RecruitingPulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)1772028-09-14
DMD
NCT07943598
P2Enrolling by invitationDuchenne Muscular Dystrophy; Exon 44202029-09-03